What is the current stock price of Valbiotis S.A. (ALVAL.PA)?

As of the latest market data, Valbiotis S.A. (ALVAL.PA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does Valbiotis S.A. (ALVAL.PA) pay a dividend?

Based on current data, Valbiotis S.A. does not have a confirmed active dividend policy.

What is the market cap of Valbiotis S.A.?

The current market capitalization of Valbiotis S.A. (ALVAL.PA) is approximately unavailable.

ALVAL.PA

Valbiotis S.A.·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.

Sector

Healthcare

Industry

Biotechnology

Employees

IPO Date

2017-06-07

Beta

-0.21

Websitewww.valbiotis.com↗